Edition:
United Kingdom

Tigenix NV (TIG.OQ)

TIG.OQ on NASDAQ Stock Exchange Global Select Market

41.98USD
25 Jul 2018
Change (% chg)

-- (--)
Prev Close
$41.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
738
52-wk High
$47.59
52-wk Low
$20.59

Chart for

About

TiGenix NV is a Belgium-based biopharmaceutical company focused on the development and commercialization of therapeutics from its platforms of allogeneic, or donor-derived, expanded stem cells. The Company's two products from the adipose-derived stem cell platform are in clinical development. Cx601 is in Phase III for the... (more)

Overall

Beta: -0.68
Market Cap(Mil.): €282.48
Shares Outstanding(Mil.): 266.49
Dividend: --
Yield (%): --

Financials

  TIG.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -0.04 -- --
ROI: -18.81 0.73 14.32
ROE: -32.21 1.82 16.04

Earnings vs. Estimates